FAQ: What Does the Research on Aires Technology Show?

More than 60 published studies and peer reviews conducted across 13+ independent institutions in 6 countries over a 33-year period (1992-2025). Key institutional partners include Pavlov Institute of Physiology (Russian Academy of Sciences, 20+ studies), Trent University Canada (Dr. Magda Havas, placebo-controlled cardiovascular studies), Vilnius Gediminas Technical University/VGTU Lithuania (3-phase resonator testing), ITMO University Russia (Springer-published simulation), UFC Performance Institute (institutional adoption study), and PACE UN ECOSOC NGO (7 independent expert peer reviews).

Nine EEG studies from the Pavlov Institute of Physiology and the Military Medical Academy show consistent normalization of brain electrical activity patterns when subjects use mobile phones or Wi-Fi devices with an Aires resonator present vs. without. Key findings: statistically significant reduction in pathological EEG indicators (slow-wave activity, hemispheric asymmetry) associated with EMF exposure; normalization replicated across multiple age groups, device types, and product generations; most recent study (Sysoev & Rybina, Pavlov Institute, 2025) showed cumulative EEG coherence improvement from 0.4 to 0.7 over 7 days of regular Lifetune ONE use.

Four cardiovascular studies show improvement in HRV and cardiovascular parameters when an Aires resonator is used during EMF exposure. Havas (Trent University, 2015): two double-blind placebo-controlled case studies using MaxPulse (FDA Class II cleared device) showed significant cardiovascular normalization. Datova (Tyumen University, 2013): HRV study in 13 subjects comparing EMF alone vs. EMF with Aires Defender. Kuznetsova (2020): ECG and HRV study with Aires Shield Pro. UFC Performance Institute: Elite UFC fighters showed improved HRV confirmed by Dr. Duncan French, SVP.

The Pavlov Institute conducted a 5-stage rat study series (2016-2019) plus a 2025 follow-up. Stage 1 (2016): Wi-Fi increased chromosome aberrations in rat bone marrow; with Aires resonator, normalization. Stage 2 (2017): DNA strand breaks in nervous system tissue; Aires normalized. Stage 3 (2017): Spatial learning and memory deficits; Aires partially restored performance. Stages 4-5: behavioral and locomotion changes normalized. 2025 (Lifetune Zone Max + Wi-Fi 6): first study showing genotype-dependent response in two rat strains. Chromosome aberration findings independently published in peer-reviewed Ecological Genetics journal (Dyuzhikova et al., 2018).

Yes. Springer-published simulation (2022): Lukyanov, Kopyltsov & Serov published a computer simulation through ICICT 2022 (Springer, doi:10.1007/978-981-19-1607-6_7) demonstrating coherent field restructuring. Thermal imaging confirmation (2026): Lukyanov published follow-up at ICICT 2026 using thermal imaging to physically confirm the resonator's electromagnetic interaction. VGTU independent testing (Lithuania, 2016-2018): three phases of engineering testing confirmed the resonator-converter's characteristic interference patterns. R&D reports confirm functional response at 2.4 GHz, 6 GHz, and 28 GHz (Wi-Fi through 5G mmWave). US Patent US12239835B2 granted March 2025.

The UFC Performance Institute (UFC PI) institutionally adopted Aires technology and conducted a study measuring its effects on elite UFC fighters. Key results: EEG brain wave improvements during and after Aires device use; faster visual and auditory reaction time measured by UFC PI's proprietary protocols; HRV improvements indicating enhanced autonomic nervous system recovery. The study was led by Dr. Duncan French, SVP of the UFC Performance Institute, who confirmed the results in published commentary. This represents one of the first elite sports institutional adoptions of an EMF resonator product.

Yes. Springer peer-reviewed conference proceedings: Lukyanov, Kopyltsov & Serov (2022) — computer simulation — published by Springer in ICICT proceedings, DOI:10.1007/978-981-19-1607-6_7. Peer-reviewed biological journal: Dyuzhikova et al. (2018 and 2019) — chromosome aberration studies in rats — published in Ecological Genetics peer-reviewed journal (DOI:10.17816/ecogen17283-92). Institutional reports: Trent University (Dr. Magda Havas) and Pavlov Institute (Russian Academy of Sciences) published formal institutional research reports. Expert peer reviews: PACE (Planetary Association for Clean Energy, UN ECOSOC NGO) independently reviewed 7 major studies and issued expert opinion letters.

Yes. Havas 2015 (Trent University): double-blind, placebo-controlled. Subject did not know whether active device or sham device was present. Experimenter was also blinded. Used FDA Class II cleared MaxPulse cardiac monitor. Pavlov Institute rat series: all stages include sham-exposure control groups and EMF-exposed-without-resonator comparison groups. EEG studies: several include baseline (no phone), EMF-only (phone without resonator), and EMF-plus-resonator conditions for within-subject comparison. VGTU engineering studies: physical measurements comparing resonator-present vs. resonator-absent conditions using calibrated laboratory equipment.

The research is specific in its scope. Studies do not claim that Lifetune devices eliminate all biological effects of EMF exposure; that devices block, absorb, or reduce EMF signal strength (they do not — the mechanism is coherent modulation, not shielding); that devices cure any disease or medical condition; or that results in rat models or case studies will necessarily generalize across all populations. What studies do claim: statistically significant normalization of specific biological markers and electrical activity patterns that were altered by EMF exposure, when the Aires resonator is present.

All published studies and expert reviews are available at the Aires Research Blog: airestech.com/blogs/research. Thematic index pages organize studies by topic: EEG & Brain Research (airestech.com/pages/research-eeg-brain), Cardiovascular & HRV Research, Animal Model Studies, Physics & Engineering Validation, 5G & Millimeter Wave Research, Clinical & Human Studies, Blood & Biological Markers, and Water Research. Timeline and summary: Research Timeline 1992-2025 and Research Program Overview at airestech.com/pages/research-overview.